Jan Mattsson, Chief Scientific Officer at ALBIREO PHARMA, INC. (ALBO), sold 200 shares at $32.92 ($7K) on 2022-04-22, disclosed to the SEC on 2022-04-25.
Scheduled sale ($7k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALBO | SELL | 2022-10-25 | $4K | — | Filing → |
| ALBO | SELL | 2022-07-25 | $5K | — | Filing → |
| ALBO | SELL | 2022-01-25 | $20K | — | Filing → |